Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY6.29 CNY
Change Today 0.00 / 0.00%
Volume 0.0
000518 On Other Exchanges
As of 10:30 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

jiangsu sihuan bioengineer-a (000518) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/17/14 - CNY6.99
52 Week Low
04/28/14 - CNY3.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JIANGSU SIHUAN BIOENGINEER-A (000518)

Related News

No related news articles were found.

jiangsu sihuan bioengineer-a (000518) Related Businessweek News

No Related Businessweek News Found

jiangsu sihuan bioengineer-a (000518) Details

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the manufacture and sale of biological agents, chemical medicines, antineoplastic agents, and health products in China. Its products include Carbamazepine tablets for central nervous system; and Ofloxacin tablets primarily used for sensitive caused urinary, reproduction, digestion, respiratory system and skin, soft tissue, and acute bacterial infections. The company was founded in 1992 and is based in Jiangyin, China.

jiangsu sihuan bioengineer-a (000518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu sihuan bioengineer-a (000518) Key Developments

Jiangsu Sihuan Bioengineering Co., Ltd, Special/Extraordinary Shareholders Meeting, Mar 20, 2015

Jiangsu Sihuan Bioengineering Co., Ltd, Special/Extraordinary Shareholders Meeting, Mar 20, 2015., at 14:30 China Standard Time. Agenda: To consider the renewal of entrusted loan for a wholly-owned subsidiary.

Jiangsu Sihuan Bioengineering Co., Ltd Approves Amendment to its Articles of Association

Jiangsu Sihuan Bioengineering Co. Ltd. approved amendment to company's articles of association, at the Extraordinary General Meeting.

Jiangsu Sihuan Bioengineering Co., Ltd Proposes Amendments to the Articles of Association

Jiangsu Sihuan Bioengineering Co. Ltd. announced that EGM will be held on December 23, 2014, to propose the amendments to the company's articles of association.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000518:CH CNY6.29 CNY 0.00

000518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000518.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000518 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU SIHUAN BIOENGINEER-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at